Actively Recruiting
Study of Immune Responses in Healthy Adults Aged 18-40 After Receiving FluMist or Inactivated Influenza Vaccine
Led by Washington University School of Medicine · Updated on 2025-09-17
30
Participants Needed
1
Research Sites
113 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the immune response in the blood, nose, and lungs after vaccination with either the FDA-approved inactivated influenza vaccine or the FDA-approved intranasal FluMist vaccine. The study focuses on healthy adults aged 18 to 40 who have not received a seasonal flu vaccine in the past nine months. The main goal is to measure changes in influenza vaccine-specific antibodies in the lower lungs and nose within 14 days after vaccination. Participants will be randomly assigned to receive either the intramuscular inactivated influenza vaccine or the intranasal FluMist vaccine on the first day of the study. Blood samples and nasopharyngeal swabs will be collected before vaccination and at several points up to 90 days after vaccination. A subgroup of 16 participants will undergo optional bronchoscopy procedures, including bronchoalveolar lavage and endobronchial biopsy, before vaccination and at days 14 and 90 to study immune responses in the lower lungs. During the study, participants will have multiple visits for sample collection and assessments over about four months. Those undergoing bronchoscopy will have additional safety lab tests and chest X-rays. Researchers will analyze antibody and immune cell changes in blood and mucosal samples to evaluate vaccine responses. The study also monitors safety and immune changes up to three months after vaccination.
CONDITIONS
Brief Title
Characterizing the Human Airway Immune Response to FluMist Vaccination
Research Team
P
Philip A. Mudd, M.D., Ph.D.
J
Jamie Mills
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here